, Bharara M, Marston W. Diabetic
foot ulcers and vascular insufﬁciency: our population has changed, but
our methods have not. J Diabetes Sci Technol 2011;52:1591-5.
24. Bradbury AW, Ruckley CV, Fowkes FGR, Forbes JF, Gillespie I,
Adam DJ, et al. Bypass versus Angioplasty in Severe Ischemia of the

JOURNAL OF VASCULAR SURGERY
January 2014

Leg (BASIL): multicentre, randomised controlled trial. Lancet
2005;366:1925-34.
25. Bradbury AW, Adams DJ, Bell J, Forbes JF, Gillespie I, Ruckley CV,
et al. Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL)
trial: a survival prediction model to facilitate clinical decision making.
J Vasc Surg 2010;51(5 Suppl):52S-68S.
26. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, et al.
Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial:
an intention-to-treat analysis of amputation-free and overall survival in
patients randomized to a bypass surgery-ﬁrst or a balloon angioplastyﬁrst revascularization strategy. J Vasc Surg 2010;51(5 Suppl):5S-17S.
27. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ,
et al. Results of PREVENT III: a multicenter, randomized trial of
edifoligide for the prevention of vein graft failure in lower extr rgery.
J Vasc Surg 2006;43:742-50.
28. Faglia E, Dalla Paola L, Clerici G, Clerissi J, Graziani L, Fusaro M,
et al. Peripheral angioplasty as the ﬁrst-choice revascularizatuion
procedure in diabetic patients with critical limb ischemia: prospective
